CMRX
Chimerix IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$801.08M
P/E Ratio
—
EPS
$-0.99
Beta
-0.18
52W High
$0.00
52W Low
$0.00
50-Day MA
$7.31
200-Day MA
$3.09
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
1.21
PEG Ratio
0.00
About Chimerix Inc
Chimerix, Inc., a developing-stage biopharmaceutical company, focuses on accelerating the advancement of various drugs that impact the lives of patients living with cancer and other serious diseases. The company is headquartered in Durham, North Carolina.
Fundamentals
| Revenue (TTM) | 212,000 |
| Gross Profit (TTM) | $-74.36M |
| EBITDA | $-96.47M |
| Operating Margin | -43074.00% |
| Return on Equity | -56.20% |
| Return on Assets | -33.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.32 |
| Price-to-Book | 6.58 |
| Price-to-Sales (TTM) | 3778.70 |
| EV/Revenue | 3159.9 |
| EV/EBITDA | 1.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1325.00% |
| Shares Outstanding | $93.80M |
| Float | $80.44M |
| % Insiders | 1.73% |
| % Institutions | 56.44% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
0.00%
HV 30-Day
0.00%
HV 60-Day
0.00%
HV Rank
—
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on CMRX and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 7/29/2026